Abstract: Certain embodiments are directed to compositions and methods for non-cytotoxic hematopoietic stem cell transplantation.

Abstract: Certain embodiments are directed to compositions and methods for non-cytotoxic hematopoietic stem cell transplantation.

Abstract: The disclosure relates to application of a compositae type cyclopeptide compound or a pharmacologically permissible salt as a cGAS-STING signal channel inhibitor and application of the compositae type cyclopeptide compound or the pharmacologically permissible salt as the cGAS-STING signal channel inhibitor in preparing a drug for treating diseases caused by abnormal activation of a cGAS-STING signal channel. As the compositae type cyclopeptide compound is a natural compound diversified in dosage form and medication mode, the compositae type cyclopeptide compound has a wide clinical application prospect.

Abstract: A light-emitting diode (LED) device includes a first epitaxial layered structure having an upper surface having different first and second regions, a second epitaxial layered structure spaced-apart disposed on the first epitaxial layered structure, a light conversion layer formed on the first region, a bonding unit disposed on the light conversion layer, the bonding unit and the light conversion layer interconnecting the first and second epitaxial layered structures, and an electrically conductive structure formed on the second region and electrically connects the first and second epitaxial layered structures. A method for manufacturing the LED device is also disclosed.

Abstract: A multi-layered tunnel junction structure adapted to be disposed between two light emitting structures includes an n-type doped insulation layer, as well as an n-type heavily doped layer, a metal atom layer, a p-type heavily doped layer, and a p-type doped insulation layer which are disposed on the n-type doped insulation layer in such sequential order. A light emitting device having the multi-layered tunnel junction structure and a production method of such light emitting device are also disclosed.

Abstract: A method for game adaption, a terminal, and a computer-readable storage medium are provided. The method for game adaption is applied to a terminal. The method includes the following. A browser-like environment is provided for a mini-game platform, where the browser-like environment includes an environment related to game development in a browser environment. When a game is running on the mini-game platform, game codes of the game is processed with the browser-like environment. The method may further include the following. The browser-like environment is updated on the mini-game platform to obtain an updated browser-like environment.

Abstract: A method for game running and related products are provided. The method is applicable to an electronic device and the method includes the following. A game to be run is determined. A first file of the game is downloaded by requesting a network. The first file is decompressed to obtain a second file decompressed. At least one game engine is called to load the second file to run the game.

Abstract: A game rendering method and a terminal are provided. The method includes the following. A rendering instruction is stored when a JS engine of the terminal receives the rendering instruction, where the rendering instruction carries a plurality of data identifiers of to-be-rendered data, a plurality of time interval identifiers corresponding to the data identifiers, and a plurality of rendering parameter identifiers corresponding to the time interval identifiers. The rendering instruction is sent to a target rendering system. A target time interval identifier corresponding to current time is determined, and a target data identifier and a target rendering parameter identifier corresponding to the target time interval identifier are determined. To-be-rendered data corresponding to the target data identifier and target rendering parameter corresponding to the target rendering parameter identifier, are determined.

Abstract: The present disclosure discloses a game rendering method and a terminal device. The terminal device includes a JS layer, a bridge layer, and a system framework layer. The method includes the follows. The JS layer transmits drawing instructions cached in an instruction set to the bridge layer, when a number of the drawing instructions cached in the instruction set is greater than or equal to a first threshold. The bridge layer obtains a rendering result by using an OpenGL capability to process the drawing instructions, and transmits the rendering result to the system framework layer. The system framework layer performs rendering based on the rendering result.

Abstract: A light emitting diode includes an n-type confinement layer, a quantum well active layer formed on the n-type confinement layer, a p-type confinement layer formed on the quantum well active layer, a gallium phosphide-based quantum dot structure formed in the p-type confinement layer, and a GaP-based current spreading layer formed on the GaP-based quantum dot structure. A method of manufacturing the light emitting diode is also provided.

Abstract: Certain embodiments are directed to compositions and methods for non-cytotoxic hematopoietic stem cell transplantation for the treatment of chronic granulomatous disease

Abstract: Certain embodiments are directed to compositions and methods for non-cytotoxic hematopoietic stem cell transplantation.

Abstract: The present invention provides an isolated nucleic acid comprising a promoter operably linked to a nucleic acid encoding a peptide or protein and/or an RNA (e.g., antisense or ribozyme), wherein the promoter comprises elements that can include, but are not limited to, a) a myeloid specific promoter element comprising a core sequence GAGGAA; b) a myeloid specific promoter element comprising a core sequence AAGGAGAAG; c) a myeloid specific promoter element comprising a core sequence TTTCCAAA; d) a myeloid specific promoter element comprising a core sequence TGTGGTTGC; e) a myeloid specific promoter element comprising a core sequence TGAGTCA; f) a myeloid associated promoter element comprising a core sequence CCGCCC; and g) any combination of (a), (b), (c), (d), (e) and/or (f), any combination of multiples of (a), (b), (c), (d), (e) and/or (f), in any order and/or in any orientation (forward or reverse).

Abstract: The present invention provides an isolated nucleic acid comprising a promoter operably linked to a nucleic acid encoding a peptide or protein and/or an RNA (e.g., antisense or ribozyme), wherein the promoter comprises elements that can include, but are not limited to, a) a myeloid specific promoter element comprising a core sequence GAGGAA; b) a myeloid specific promoter element comprising a core sequence AAGGAGAAG; c) a myeloid specific promoter element comprising a core sequence TTTCCAAA; d) a myeloid specific promoter element comprising a core sequence TGTGGTTGC; e) a myeloid specific promoter element comprising a core sequence TGAGTCA; f) a myeloid associated promoter element comprising a core sequence CCGCCC; and g) any combination of (a), (b), (c), (d), (e) and/or (f), any combination of multiples of (a), (b), (c), (d), (e) and/or (f), in any order and/or in any orientation (forward or reverse).